During JD-SW (09618.HK) -4.200 (-3.055%) Short selling $212.99M; Ratio 22.215% (JD.US) 's “Double 11” period, JD HEALTH (06618.HK) -0.500 (-1.832%) Short selling $26.41M; Ratio 25.137% entered into a strategic cooperation agreement with Swisse, inne, Schiff Move Free, GNC, WonderLab and other brands. In the next 3 years, JD HEALTH will work with the six major brands to achieve a 300% increase in sales through resource integration and complementary strengths, and jointly advance the health industry into a new stage of diversified integration and innovative development.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2024-11-25 12:25.) (Real-time Streaming US Stocks Quote; Except All OTC quotes are at least 15 minutes delayed.)Related NewsNomura Elevates JD HEALTH (06618.HK) TP to $31 as Pharmaceutical Sales Lead Rev. Growth